BLU-451, a CNS-Active, Potent, and Selective Small-Molecule Inhibitor Against Uncommon EGFR Mutations

Yves Millet(Blueprint Medicines (United States)), Xiuning Le(The University of Texas MD Anderson Cancer Center)
Molecular Cancer Therapeutics
May 13, 2026
Cited by 0


Related Papers

No related papers found

Powered by citation graph analysis